Similarly, in the EmCB sub-study of individuals not taking statins, there was no correlation between PCSK9 levels and LDL cholesterol in either those with CAD (rs = −0.00840, p = 0.862, N = 429) or controls (rs = −0.00742, p = 0.895, N = 322). Here, PCSK9 is linked to coronary artery disorder.